主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AYTU
#3661
AYTU BioPharma, Inc. Common Stock
2.5
7
+3.21%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.21%
每月变动
-3.02%
6个月变化
+7.98%
年变化
+102.36%
前一天收盘价
2.4
9
Open
2.5
7
Bid
Ask
Low
2.5
7
High
2.5
7
交易量
1
市场
股票
医疗保健
AYTU
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
26 M
28.8 M
5.1 M
1.39 M
1.94 M
3.28 M
Cash from investing activities
2.78 M
3.25 M
117 K
329 K
2.56 M
2.05 M
Cash from financing activities
30.31 M
1.53 M
8.87 M
1.26 M
15.44 M
17.56 M
Free cash flow
26 M
28.8 M
5.1 M
1.39 M
-1.29 M
3.26 M
新闻
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
财报电话会议实录:Aytu BioPharma 2026财年第二季度收入下滑,股价下跌
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma股价在抑郁症药物EXXUA商业发布后上涨
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA
Aytu BioPharma在美国市场推出抑郁症药物EXXUA
Aytu BioPharma launches depression drug EXXUA in U.S. market